Cargando…
Randomised controlled trials for COVID-19: evaluation of optimal randomisation methodologies—need for data validation of the completed trials and to improve ongoing and future randomised trial designs
During the emerging COVID-19 (coronavirus disease 2019) pandemic, initially there were no proven treatment options. With the release of randomised controlled trial (RCT) results, we are beginning to see possible treatment options for COVID-19. The RECOVERY trial showed an absolute risk reduction in...
Autores principales: | Emani, Venkata R., Goswami, Sanjeev, Nandanoor, Dheeraj, Emani, Shaila R., Reddy, Nidhi K., Reddy, Raghunath |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659806/ https://www.ncbi.nlm.nih.gov/pubmed/33189891 http://dx.doi.org/10.1016/j.ijantimicag.2020.106222 |
Ejemplares similares
-
Changing Dynamics of COVID-19 Deaths During the SARS-CoV2 B.1.617.2 (Delta Variant) Outbreak in England and Wales: Reduced COVID-19 Deaths Among the Care Home Residents
por: Emani, Venkata R., et al.
Publicado: (2022) -
Preexisting conditions among the SARS-CoV2 deaths during the SARS-CoV2 B.1.617.2 (Delta variant) outbreak in the United Kingdom
por: Emani, Venkata R., et al.
Publicado: (2022) -
Methodological bias in cluster randomised trials
por: Hahn, Seokyung, et al.
Publicado: (2005) -
Changes to aspects of ongoing randomised controlled trials with fixed designs
por: Coskinas, Xanthi, et al.
Publicado: (2020) -
Registry randomised trials: a methodological perspective
por: Doherty, Dorota A, et al.
Publicado: (2023)